![](/img/cover-not-exists.png)
Rituximab Using A Thrice Weekly Dosing Schedule in B-Cell Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Demonstrates Clinical Activity and Acceptable Toxicity
Byrd, John C., Murphy, Timothy, Howard, Robin S., Lucas, Margaret S., Goodrich, Amy, Park, Kathy, Pearson, Michael, Waselenko, Jamie K., Ling, Geoffrey, Grever, Michael R., Grillo-Lopez, Antonio J., RVolume:
19
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2001.19.8.2153
Date:
April, 2001
File:
PDF, 766 KB
english, 2001